Company profile · Onderzoeks- & kennisinstelling
Cell4Pharma
- Biotechnology
- Onderzoeks- & kennisinstelling
- Oss
- Biotechnology · Oss
- Employees
- 11–50
- Province
- Noord-Brabant
- Country
- Netherlands
About Cell4Pharma
We envision a world without a risk for renal toxicity for compounds entering clinical stages of drug development.
Cell4Pharma aims to reduce the failure rate in late clinical stages due to renal tox below 3% market wide within the next 10 years. Without the use of animal experimentation.
This ambition is supported by our human renal cell line ciPTEC validated during extensive collaborations with the pharmaceutical industry. More than 10 years of research lead to the development of robust cell-based assays focusing on the detection of highly specific biomarkers for renal toxicity.
Team by function
Based on 4 public job profiles as of 4 August 2026.
- Research / R&D2
- Founder / Owner1
- Healthcare / Medical1
Similar companies
Companies with a similar profile, Noord-Brabant first.
Biocult
Biotechnology · Uden
11–50 employeesView profile
Hycult Biotech
Biotechnology · Uden
11–50 employeesView profile
NTRC Therapeutics B.V.
Biotechnology · Oss
11–50 employeesView profile
Citryll
Biotechnology · Oss
11–50 employeesView profile
CytoSMART Technologies
Biotechnology · Eindhoven
51–200 employeesView profile
Looking for more companies like these?
Get a free selection by email, put together by our team.